Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Membrane Potential Mapping with 18F-TPP
NCT07506616Phase 1Recruiting
- Sponsor
- Yale University
- Start
- Oct 2026
- Primary completion
- Aug 2033
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of BFPET, sponsored by Yale University. Primary endpoint: Tracers volume of distribution up to 90 days. Started Oct 2026; status: recruiting.
02
Drugs
BFPET
Beyond the preview
Go deeper on NCT07506616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07506616.